Citations (66)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Chiranjeevi Pasala, Chandra Sekhar Reddy Chilamakuri, Sudheer Kumar Katari, Ravina Madhulitha Nalamolu, Aparna R. Bitla & Umamaheswari Amineni. (2019) Epitope-driven common subunit vaccine design against H. pylori strains. Journal of Biomolecular Structure and Dynamics 37:14, pages 3740-3750.
Read now
Read now
David Stubljar, Tomislav Jukic & Alojz Ihan. (2018) How far are we from vaccination against Helicobacter pylori infection?. Expert Review of Vaccines 17:10, pages 935-945.
Read now
Read now
Nasrin Mirzaei, Farkhondeh Poursina, Sharareh Moghim, Niloufar Rashidi & Hajieh Ghasemian Safaei. (2017) The study of H. pylori putative candidate factors for single- and multi-component vaccine development. Critical Reviews in Microbiology 43:5, pages 631-650.
Read now
Read now
Morteza Milani, Yaeghob Sharifi, Mohammad Rahmati-Yamchi, Mohammad H Somi & Abolfazl Akbarzadeh. (2015) Immunology and vaccines and nanovaccines for Helicobacter pylori infection. Expert Review of Vaccines 14:6, pages 833-840.
Read now
Read now
Inês C Gonçalves, Patrícia C Henriques, Catarina L Seabra & M Cristina L Martins. (2014) The potential utility of chitosan micro/nanoparticles in the treatment of gastric infection. Expert Review of Anti-infective Therapy 12:8, pages 981-992.
Read now
Read now
Michael Selgrad, Jan Bornschein & Peter Malfertheiner. (2011) Guidelines for treatment of Helicobacter pylori in the East and West. Expert Review of Anti-infective Therapy 9:8, pages 581-588.
Read now
Read now
Malin Sundquist & Marianne Quiding-Järbrink. (2010) Helicobacter pylori and its effect on innate and adaptive immunity: new insights and vaccination strategies. Expert Review of Gastroenterology & Hepatology 4:6, pages 733-744.
Read now
Read now
Edith Lahner, Giulia Bernardini, Annalisa Santucci & Bruno Annibale. (2010) Helicobacter pylori immunoproteomics in gastric cancer and gastritis of the carcinoma phenotype. Expert Review of Proteomics 7:2, pages 239-248.
Read now
Read now
Articles from other publishers (58)
Zelin Zhang, Xingchi Chen, Bin Li, Tingting Xia, Xiaobin Wu & Chao Wu. (2023)
Helicobacter pylori
induces urease subunit B‐specific CD8
+
T cell responses in infected individuals via cytosolic pathway of cross‐presentation
. Helicobacter.
Crossref
Crossref
Taojun He, Fang Zhang, Jin Zhang, Shanshan Wei, Jie Ning, Hanmei Yuan & Bin Li. (2023)
UreB
immunodominant epitope‐specific
CD8
+
T‐cell responses were beneficial in reducing gastric symptoms in
Helicobacter pylori
‐infected individuals
. Helicobacter 28:3.
Crossref
Crossref
Phillip R. Pittman, Gunnstein Norheim, Benjamin Pierson & Fernando B. Guerena. 2023. Plotkin's Vaccines. Plotkin's Vaccines
172
190.e9
.
Amir Ghasemi, Shifeng Wang, Bikash Sahay, Jeffrey R. Abbott & Roy CurtissIIIIII. (2022) Protective immunity enhanced Salmonella vaccine vectors delivering Helicobacter pylori antigens reduce H. pylori stomach colonization in mice. Frontiers in Immunology 13.
Crossref
Crossref
Peter Malfertheiner, Francis Megraud, Theodore Rokkas, Javier P Gisbert, Jyh-Ming Liou, Christian Schulz, Antonio Gasbarrini, Richard H Hunt, Marcis Leja, Colm O'Morain, Massimo Rugge, Sebastian Suerbaum, Herbert Tilg, Kentaro Sugano & Emad M El-Omar. (2022)
Management of
Helicobacter pylori
infection: the Maastricht VI/Florence consensus report
. Gut 71:9, pages 1724-1762.
Crossref
Crossref
Ruiyi Deng, Huiling Zheng, Hongzhen Cai, Man Li, Yanyan Shi & Shigang Ding. (2022) Effects of helicobacter pylori on tumor microenvironment and immunotherapy responses. Frontiers in Immunology 13.
Crossref
Crossref
Pratik Ghosh, Swarnav Bhakta, Manojit Bhattacharya, Ashish Ranjan Sharma, Garima Sharma, Sang-Soo Lee & Chiranjib Chakraborty. (2021) A Novel Multi-Epitopic Peptide Vaccine Candidate Against Helicobacter pylori: In-Silico Identification, Design, Cloning and Validation Through Molecular Dynamics. International Journal of Peptide Research and Therapeutics 27:2, pages 1149-1166.
Crossref
Crossref
Eileen Crowley & Séamus Hussey. 2021. Pediatric Gastrointestinal and Liver Disease. Pediatric Gastrointestinal and Liver Disease
275
292.e12
.
Nabendu Debnath, Ashok Kumar Yadav & Ashish Tyagi. 2021. Advances in Probiotics. Advances in Probiotics
187
201
.
Nabendu Debnath & Ashok Kumar Yadav. 2021. Probiotic Research in Therapeutics. Probiotic Research in Therapeutics
215
230
.
Nabendu Debnath & Ashok Kumar Yadav. 2021. Probiotic Research in Therapeutics. Probiotic Research in Therapeutics
167
189
.
David Y. Graham. 2021.
Junchang Wang, Yiyue Zhang, Yirong Zhu, Junru Liu, Yan Chen, Xin Cao & You Yang. (2020)
Total Synthesis and Immunological Evaluation of the Tri-
d
-
glycero
-
d
-
manno
-heptose Antigen of the Lipopolysaccharide as a Vaccine Candidate against
Helicobacter pylori
. Organic Letters 22:22, pages 8780-8785.
Crossref
Crossref
Guangzong Tian, Chunjun Qin, Zhonghua Liu, Dacheng Shen, Xiaopeng Zou, Junjie Fu, Jing Hu, Peter H. Seeberger & Jian Yin. (2020)
Total synthesis of the
Helicobacter pylori
serotype O2 O-antigen α-(1 → 2)- and α-(1 → 3)-linked oligoglucosides
. Chemical Communications 56:3, pages 344-347.
Crossref
Crossref
Thomas F. Meyer & Pau Morey. 2020. Mucosal Vaccines. Mucosal Vaccines
579
596
.
Yu. P. Uspenskiy, N. V. Baryshnikova, E. I. Ermolenko, A. N. Suvorov & A. V. Svarval. (2019) Anti-Helicobacter pylori vaccine: mith or reality?. Russian Journal of Infection and Immunity 9:3-4, pages 457-466.
Crossref
Crossref
Sandra Salillas, Miriam Alías, Valérie Michel, Alejandro Mahía, Ainhoa Lucía, Liliana Rodrigues, Jessica Bueno, Juan José Galano-Frutos, Hilde De Reuse, Adrián Velázquez-Campoy, José Alberto Carrodeguas, Carlos Sostres, Javier Castillo, José Antonio Aínsa, María Dolores Díaz-de-Villegas, Ángel Lanas, Eliette Touati & Javier Sancho. (2019)
Design, Synthesis, and Efficacy Testing of Nitroethylene- and 7-Nitrobenzoxadiazol-Based Flavodoxin Inhibitors against
Helicobacter pylori
Drug-Resistant Clinical Strains and in
Helicobacter pylori
-Infected Mice
. Journal of Medicinal Chemistry 62:13, pages 6102-6115.
Crossref
Crossref
Chiranjeevi Pasala, Sudheer Kumar Katari, Ravina Madhulitha Nalamolu, Aparna R. Bitla & Umamaheswari Amineni. (2019) Hierarchical-Clustering, Scaffold-Mining Exercises and Dynamics Simulations for Effectual Inhibitors Against Lipid-A Biosynthesis of Helicobacter pylori. Cellular and Molecular Bioengineering 12:3, pages 255-274.
Crossref
Crossref
Hiroshi Matsumoto, Akiko Shiotani & David Y. Graham. 2019. Helicobacter pylori in Human Diseases. Helicobacter pylori in Human Diseases
211
225
.
Peter Malfertheiner, Michael Selgrad, Thomas Wex, Benedetta Romi, Erica Borgogni, Fabiana Spensieri, Luisanna Zedda, Paolo Ruggiero, Laura Pancotto, Stefano Censini, Emanuela Palla, Niranjan Kanesa-Thasan, Bruce Scharschmidt, Rino Rappuoli, David Y Graham, Francesca Schiavetti & Giuseppe Del Giudice. (2018) Efficacy, immunogenicity, and safety of a parenteral vaccine against Helicobacter pylori in healthy volunteers challenged with a Cag-positive strain: a randomised, placebo-controlled phase 1/2 study. The Lancet Gastroenterology & Hepatology 3:10, pages 698-707.
Crossref
Crossref
Xiaopeng Zou, Chunjun Qin, Claney L. Pereira, Guangzong Tian, Jing Hu, Peter H. Seeberger & Jian Yin. (2018)
Synergistic Glycosylation as Key to the Chemical Synthesis of an Outer Core Octasaccharide of
Helicobacter pylori
. Chemistry - A European Journal 24:12, pages 2868-2872.
Crossref
Crossref
Phillip R. Pittman & Stanley A. Plotkin. 2018. Plotkin's Vaccines. Plotkin's Vaccines
149
160.e7
.
Beatriz Meza, Felipe Ascencio, Arturo Pedro Sierra-Beltrán, Javier Torres & Carlos Angulo. (2017) A novel design of a multi-antigenic, multistage and multi-epitope vaccine against Helicobacter pylori: An in silico approach. Infection, Genetics and Evolution 49, pages 309-317.
Crossref
Crossref
Aleksandra Djekic & Anne Müller. (2016) The Immunomodulator VacA Promotes Immune Tolerance and Persistent Helicobacter pylori Infection through Its Activities on T-Cells and Antigen-Presenting Cells. Toxins 8:6, pages 187.
Crossref
Crossref
Weiran Shan, Hsiang-fu Kung & Ruiguang Ge. (2016)
Comparison of Iron-Binding Ability Between Thr70-NapA and Ser70-NapA of
Helicobacter pylori
. Helicobacter 21:3, pages 192-200.
Crossref
Crossref
Kenneth S. Rosenthal, Joseph R. Sikon & Aaron Kuntz. (2016) Why Don't We Have a Vaccine Against……….? Part 3. Bacteria, Too. Infectious Diseases in Clinical Practice 24:3, pages 183-189.
Crossref
Crossref
Bin Li, Li Chen, Heqiang Sun, Wuchen Yang, Jian Hu, Yafei He, Shanshan Wei, Zhuo Zhao, Jinyong Zhang, Haibo Li, Quanming Zou & Chao Wu. (2015) Immunodominant epitope-specific Th1 but not Th17 responses mediate protection against Helicobacter pylori infection following UreB vaccination of BALB/c mice. Scientific Reports 5:1.
Crossref
Crossref
Ming Zeng, Xu-Hu Mao, Jing-Xin Li, Wen-De Tong, Bin Wang, Yi-Ju Zhang, Gang Guo, Zhi-Jing Zhao, Liang Li, De-Lin Wu, Dong-Shui Lu, Zhong-Ming Tan, Hao-Yu Liang, Chao Wu, Da-Han Li, Ping Luo, Hao Zeng, Wei-Jun Zhang, Jin-Yu Zhang, Bo-Tao Guo, Feng-Cai Zhu & Quan-Ming Zou. (2015) Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet 386:10002, pages 1457-1464.
Crossref
Crossref
Pier-Luigi Lollini, Federica Cavallo, Patrizia Nanni & Elena Quaglino. (2015) The Promise of Preventive Cancer Vaccines. Vaccines 3:2, pages 467-489.
Crossref
Crossref
Peter Malfertheiner, Alexander Link & Michael Selgrad. (2014) Helicobacter pylori: perspectives and time trends. Nature Reviews Gastroenterology & Hepatology 11:10, pages 628-638.
Crossref
Crossref
Sukhbir K Shahid. (2014)
Novel anti
-Helicobacter pylori
therapies
. Pharmaceutical Patent Analyst 3:4, pages 411-427.
Crossref
Crossref
Paolo Ruggiero & Stefano Censini. (2014) Helicobacter pylori: A Brief History of a Still Lacking Vaccine. Diseases 2:2, pages 187-208.
Crossref
Crossref
Eleonora Altman, Vandana Chandan & Blair Harrison. (2013) The potential of dextran-based glycoconjugates for development of Helicobacter pylori vaccine. Glycoconjugate Journal 31:1, pages 13-24.
Crossref
Crossref
Kwong Ming Fock, David Y. Graham & Peter Malfertheiner. (2013) Helicobacter pylori research: historical insights and future directions. Nature Reviews Gastroenterology & Hepatology 10:8, pages 495-500.
Crossref
Crossref
Alison L. Every. (2013) Key host–pathogen interactions for designing novel interventions against Helicobacter pylori. Trends in Microbiology 21:5, pages 253-259.
Crossref
Crossref
Vandana Chandan, Anthony H.T. Jeremy, Michael F. Dixon, Eleonora Altman & Jean E. Crabtree. (2013)
Colonization of gerbils with
Helicobacter pylori
O-chain-deficient mutant SS1 HP0826::Kan results in gastritis and is associated with
de novo
synthesis of extended homopolymers
. Pathogens and Disease 67:2, pages 91-99.
Crossref
Crossref
Phillip R. Pittman & Stanley A. Plotkin. 2013. Vaccines. Vaccines
1008
1017
.
Hai-Bo Li, Jin-Yong Zhang, Ya-Fei He, Li Chen, Bin Li, Kai-Yun Liu, Wu-Chen Yang, Zhuo Zhao, Quan-Ming Zou & Chao Wu. (2012) Systemic immunization with an epitope-based vaccine elicits a Th1-biased response and provides protection against Helicobacter pylori in mice. Vaccine 31:1, pages 120-126.
Crossref
Crossref
Marina Ulanova, Raymond Tsang & Eleonora Altman. (2012) Neglected infectious diseases in Aboriginal communities: Haemophilus influenzae serotype a and Helicobacter pylori. Vaccine 30:49, pages 6960-6966.
Crossref
Crossref
Eleonora Altman, Vandana Chandan, Blair A. Harrison, Roberto Veloso-Pita, Jianjun Li, Rhonda KuoLee, Wangxue Chen & Vicente Vérez-Bencomo. (2012) Design and immunological properties of Helicobacter pylori glycoconjugates based on a truncated lipopolysaccharide lacking Lewis antigen and comprising an α-1,6-glucan chain. Vaccine 30:50, pages 7332-7341.
Crossref
Crossref
Monika Adamczyk-Poplawska, Sergiusz Markowicz & Elzbieta K. Jagusztyn-Krynicka. (2011) Proteomics for development of vaccine. Journal of Proteomics 74:12, pages 2596-2616.
Crossref
Crossref
Paul Swain. (2011) Future Innovative Therapies to Treat Upper Gastrointestinal Bleeding. Gastrointestinal Endoscopy Clinics of North America 21:4, pages 739-747.
Crossref
Crossref
Luiz Edmundo Mazzoleni, Carlos Fernando Francesconi & Guilherme Becker Sander. (2011) Mass eradication of Helicobacter pylori: feasible and advisable?. The Lancet 378:9790, pages 462-464.
Crossref
Crossref
Jan Bornschein & Peter Malfertheiner. (2011) Gastric carcinogenesis. Langenbeck's Archives of Surgery 396:6, pages 729-742.
Crossref
Crossref
S. De Flora & P. Bonanni. (2011) The prevention of infection-associated cancers. Carcinogenesis 32:6, pages 787-795.
Crossref
Crossref
Mario A. Monteiro, Stacey Britton, Lisa A. Applebee & Shahida Baqar. (2011) Synthesis and immunogenicity of a Helicobacter pylori lipopolysaccharide-based conjugate. Vaccine 29:17, pages 3098-3102.
Crossref
Crossref
Encarna Velázquez, Álvaro Peix & Alberto Gómez-Alonso. (2011) Microorganismos y cáncer: evidencias científicas y nuevas hipótesis. Cirugía Española 89:3, pages 136-144.
Crossref
Crossref
Ianko D. Iankov, Iana H. Haralambieva & Evanthia Galanis. (2011) Immunogenicity of attenuated measles virus engineered to express Helicobacter pylori neutrophil-activating protein. Vaccine 29:8, pages 1710-1720.
Crossref
Crossref
Encarna Velázquez, Álvaro Peix & Alberto Gómez-Alonso. (2011) Microorganisms and cancer: Scientific evidence and new hypotheses. Cirugía Española (English Edition) 89:3, pages 136-144.
Crossref
Crossref
Séamus Hussey & Nicola L. Jones. 2011. Pediatric Gastrointestinal and Liver Disease. Pediatric Gastrointestinal and Liver Disease
293
308.e10
.
David Spaner & Angela Bahlo. 2011. Experimental and Applied Immunotherapy. Experimental and Applied Immunotherapy
37
57
.
Peter Malfertheiner & Michael Selgrad. (2010) Helicobacter pylori infection and current clinical areas of contention. Current Opinion in Gastroenterology 26:6, pages 618-623.
Crossref
Crossref
Michael Selgrad, Jan Bornschein, Theodore Rokkas & Peter Malfertheiner. (2010) Clinical Aspects of Gastric Cancer and Helicobacter pylori- Screening, Prevention, and Treatment. Helicobacter 15, pages 40-45.
Crossref
Crossref
Toni Aebischer, Thomas F. Meyer & Leif P. Andersen. (2010) Inflammation, Immunity, and Vaccines for Helicobacter. Helicobacter 15, pages 21-28.
Crossref
Crossref
Chih-Ho Lai, Yerra Koteswara Rao, Shih-Hua Fang, Yu-Ting Sing & Yew-Min Tzeng. (2010) Identification of 3′,4′,5′-trimethoxychalcone analogues as potent inhibitors of Helicobacter pylori-induced inflammation in human gastric epithelial cells. Bioorganic & Medicinal Chemistry Letters 20:18, pages 5462-5465.
Crossref
Crossref
Blaise Corthésy. (2010) Role of secretory immunoglobulin A and secretory component in the protection of mucosal surfaces. Future Microbiology 5:5, pages 817-829.
Crossref
Crossref
C Follmer. (2010) Ureases as a target for the treatment of gastric and urinary infections. Journal of Clinical Pathology 63:5, pages 424-430.
Crossref
Crossref
Manas Kumar Roy, Sagar Sadhu & Sanjay Kumar Dubey. (2010) Advances in the management of gastric cancer. Indian Journal of Surgery 71:6, pages 342-349.
Crossref
Crossref